[go: up one dir, main page]

MY180091A - Vaccines and vaccine compositions, and methods for the manufacture thereof - Google Patents

Vaccines and vaccine compositions, and methods for the manufacture thereof

Info

Publication number
MY180091A
MY180091A MYPI2012700599A MYPI2012700599A MY180091A MY 180091 A MY180091 A MY 180091A MY PI2012700599 A MYPI2012700599 A MY PI2012700599A MY PI2012700599 A MYPI2012700599 A MY PI2012700599A MY 180091 A MY180091 A MY 180091A
Authority
MY
Malaysia
Prior art keywords
neuraminidase
derived
vaccines
manufacture
methods
Prior art date
Application number
MYPI2012700599A
Inventor
Chanpen Chamnanpood
Phanchana Sanguansermsri
Donruedee Sanguansermsri
Original Assignee
Agricultural Res Development Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Res Development Agency filed Critical Agricultural Res Development Agency
Priority to MYPI2012700599A priority Critical patent/MY180091A/en
Publication of MY180091A publication Critical patent/MY180091A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A vaccine including inactivated influenza A viruses that include or carry H5 hemagglutinin and at least one neuraminidase of a subtype selected from a group including N1, N2, N5, N6, N7, and N8 neuraminidase. The H5 hemagglutinin can be derived from A/chicken/Thailand/704/77. The N1 neuraminidase can be derived from type A/Puerto Rico/9/1934, the N2 neuraminidase can be derived from A/Singapore/1/57, the N5 neuraminidase can be derived from type A/Duck/Alberta/60/1976, the N6 neuraminidase can be derived from A/gull/Maryland/704/77, the N7 neuraminidase can be derived from A/chicken/Germany/N/49, and the N8 neuraminidase can be derived from A/duck/Australia/341/83. Fig. 1
MYPI2012700599A 2010-03-05 2010-03-05 Vaccines and vaccine compositions, and methods for the manufacture thereof MY180091A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2012700599A MY180091A (en) 2010-03-05 2010-03-05 Vaccines and vaccine compositions, and methods for the manufacture thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/TH2010/000009 WO2011108999A1 (en) 2010-03-05 2010-03-05 Vaccines and vaccine compositions, and methods for the manufacture thereof
MYPI2012700599A MY180091A (en) 2010-03-05 2010-03-05 Vaccines and vaccine compositions, and methods for the manufacture thereof

Publications (1)

Publication Number Publication Date
MY180091A true MY180091A (en) 2020-11-21

Family

ID=44542452

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012700599A MY180091A (en) 2010-03-05 2010-03-05 Vaccines and vaccine compositions, and methods for the manufacture thereof

Country Status (3)

Country Link
MY (1) MY180091A (en)
PH (1) PH12012501712A1 (en)
WO (1) WO2011108999A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013185177A1 (en) * 2012-06-12 2013-12-19 Csl Limited Influenza vaccine
CN104312983B (en) * 2014-10-20 2017-04-12 中国疾病预防控制中心病毒病预防控制所 Recombinant influenza virus and application thereof
RU2605822C2 (en) * 2015-03-13 2016-12-27 Виталий Александрович Сергеев Fast nonimmune protection - a new strategy for vaccinal prevention of infectious diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2581093B1 (en) * 2003-06-16 2015-03-18 MedImmune, LLC Influenza hemagglutinin and neuraminidase variants
US9072701B2 (en) * 2006-04-21 2015-07-07 St. Jude Children's Research Hospital Avian influenza viruses, vaccines, compositions, formulations, and methods

Also Published As

Publication number Publication date
WO2011108999A1 (en) 2011-09-09
PH12012501712A1 (en) 2019-07-03

Similar Documents

Publication Publication Date Title
WO2012024621A3 (en) Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
MX2021001053A (en) Influenza virus vaccines and uses thereof.
MX2014003308A (en) Influenza virus vaccines and uses thereof.
SG10201912944QA (en) Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
PH12016500486A1 (en) Aza-pyridone compounds and uses thereof
MX2012009581A (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease.
NZ606087A (en) Influenza vaccine
EP3471767A4 (en) Influenza virus hemagglutinin proteins and uses thereof
IL227947A0 (en) Compositions comprising antibodies binding the hemagglutinin (ha) glycoprotein and the extracellular domain of the matrix 2 ectodomain (m2e) polypeptide of an influenza virus and uses thereof
ZA202004538B (en) Influenza virus vaccines and uses thereof
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
EA201290897A1 (en) VACCINES FOR PANDEMIC FLU
WO2016100926A8 (en) Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza
IL279719A (en) Influenza virus hemagglutinin mutants
WO2012060678A3 (en) Novel vaccines against the a/h1n1 pandemic flu virus
PH12014500369A1 (en) Influenza h5 vaccines
MY180091A (en) Vaccines and vaccine compositions, and methods for the manufacture thereof
MX2018014955A (en) Equine influenza virus live-attenuated vaccines.
WO2012058493A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
MX343411B (en) Influenza hemagglutinin and neuraminidase variants.
WO2011138032A3 (en) Universal influenza vaccines and methods for their generation
HK1249864A1 (en) Modified h7 hemaggluttinin glycoprotein of the influenza a/shanghai/2/2013 h7 sequence
MX2014001158A (en) Recombinant swine influenza virus and uses thereof.
WO2015196180A3 (en) Influenza vaccines and methods of use thereof
GB2547494A (en) Monovalent H5 vaccine